Translational Development Acquisition Corp. (TDACU) EPS (Basic) (2024 - 2026)
Translational Development Acquisition's (TDACU) quarterly EPS (Basic) came in at $0.02 in Q1 2026, down 75.74% YoY from $0.07 in Q1 2025, and up 111.8% on a QoQ basis from -$0.14 in Q4 2025.
Translational Development Acquisition Corp. (TDACU) EPS (Basic) (2024 - 2026) Analysis & Trends
Translational Development Acquisition (TDACU) has 3 years of EPS (Basic) data on file, last reported at $0.02 in Q1 2026.
- Quarterly EPS (Basic) fell 75.74% year-over-year to $0.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.03 (down 59.78% YoY) and the FY2025 annual result came in at $0.08, up 6055.32% from the prior year.
- EPS (Basic) grew to $0.02 in Q1 2026, from -$0.14 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.08 in Q3 2025 to a low of -$0.14 in Q4 2025.
- A 3-year average of $0.01 and a median of $0.02 in 2026 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 600.8% in 2025, down 1080.95% in 2025.
- Tracing TDACU's EPS (Basic) over 3 years: stood at $0.01 in 2024, then tumbled by 1080.95% to -$0.14 in 2025, then soared by 111.8% to $0.02 in 2026.
- The last three EPS (Basic) figures came in at $0.02 (Q1 2026), -$0.14 (Q4 2025), and $0.08 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | -0.14 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.07 |
| Mar 31, 2025 | 0.07 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | -0.02 |